Home/Filings/4/0001140361-24-040228
4//SEC Filing

GILMAN STEVEN C 4

Accession 0001140361-24-040228

CIK 0000887359other

Filed

Sep 4, 8:00 PM ET

Accepted

Sep 5, 4:06 PM ET

Size

8.4 KB

Accession

0001140361-24-040228

Insider Transaction Report

Form 4
Period: 2024-09-04
Transactions
  • Exercise/Conversion

    Common Stock

    2024-09-04$3.74/sh+5,000$18,70016,000 total
  • Sale

    Common Stock

    2024-09-04$48.58/sh5,000$242,90011,000 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-09-04+5,0000 total
    Exercise: $3.74Common Stock (5,000 underlying)
Footnotes (3)
  • [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024.
  • [F2]These options, representing the right to purchase 5,000 shares, became exercisable in three installments, contingent upon continued service to the Company, with the first vesting date on March 20, 2015, which was the date on which the option was granted, and the final vesting date on May 1, 2015.
  • [F3]These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025.

Issuer

Vericel Corp

CIK 0000887359

Entity typeother

Related Parties

1
  • filerCIK 0001379970

Filing Metadata

Form type
4
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 4:06 PM ET
Size
8.4 KB